Cd44 binding peptides

一种蛋白质、基因的技术，应用在蛋白质领域，能够解决代价高昂、生产方法复杂等问题

Inactive Publication Date: 2016-10-26
EXCHANGE IMAGING TECH GMBH
View PDF26 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

As a result, the production methods described are complex, costly and have to strictly comply with regulatory requirements

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Cd44 binding peptides
  • Cd44 binding peptides
  • Cd44 binding peptides

Examples

Experimental program
Comparison scheme
Effect test

Embodiment approach

[0210] As one embodiment of the present invention, the composition is prepared by using CD44ex9-binding protein or CD44v5 peptide with stable human serum albumin. To this end, CD44ex9 binding protein or CD44v5 peptide was prepared by lyophilization with human serum albumin in vials.

[0211] In certain embodiments, the pharmaceutical composition further comprises one or more other drugs that are toxins, cytokines, cytostatic agents, or immunomodulators.

[0212] As used herein, the term "pharmaceutically acceptable carrier" is intended to include any and all solvents, solubilizers, fillers, stabilizers, binders, absorbents, bases, buffers, lubricants, release-controlling Excipients, diluents, emulsifiers, humectants, lubricants, dispersion media, coatings, antibacterial or antifungal agents, isotonic and absorption delaying agents, and the like are compatible carriers for pharmaceutical administration. Such media and agents for pharmaceutically active substances are known in ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention relates to a protein which binds to the domain encoded by exon 9 of human CD44 (CD44ex9), to fusion proteins and conjugates of said protein and especially to nanoparticles conjugated to said protein. The invention further relates to a method of production for the protein and the respective conjugated nanoparticles and the use of the protein of the invention for treatment and diagnosis of cancer diseases.

Description

technical field [0001] The present invention relates to a protein that binds to a region encoded by exon 9 of the human CD44 gene (CD44ex9) to fuse and couple to the protein, and in particular to nanoparticles coupled to the protein. The present invention also relates to a method for the production of said proteins and corresponding conjugated nanoparticles, to CD44V5-derived peptides, and to the use of the proteins and peptides of the present invention in the treatment and diagnosis of various diseases, especially in the treatment and Applications in the diagnosis of cancer. Background technique [0002] Extensive studies of cancer transcriptional patterns have led to the discovery of molecular targets to distinguish malignant from benign tumors and the most aggressive tumors from those that are less aggressive. Cancers tend to overexpress some proteins, including certain cell surface antigens, for example, cell surface receptors. Antibodies that bind to these overexpress...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K38/16C07K14/705A61P35/00C12N15/11
CPCA61K38/00A61K49/0056A61K49/0067G01N33/587G01N2333/70585A61K47/62A61K47/6929C07K14/70585A61P1/04A61P17/04A61P25/00A61P29/00A61P35/00A61P37/08A61P3/10A61K38/1709C07K5/06G01N33/574G01N33/57492
Inventor 克劳迪娅·阿恩茨沃尔夫冈·格雷布
Owner EXCHANGE IMAGING TECH GMBH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap